Advertisements
Advertisements
प्रश्न
Human insulin is being commercially produced form a transgenic species of ______.
विकल्प
Escherichia
Mycobacterium
Rhizobium
Saccharomyces.
Advertisements
उत्तर
Human insulin is being commercially produced forma transgenic species of Escherichia.
Explanation:
E.coli that has been genetically modified to produce human fusulin. Insulin-producing genes from humans were introduced into E.coli bacteria, which produced insulin dubbed 'humulin' for clinical use, utilizing genetic engineering or recombinant DNA technology.
APPEARS IN
संबंधित प्रश्न
Explain enzyme – replacement therapy to treat adenosine deaminase deficiency. Mention two disadvantages of this procedure.
Recombination DNA−technology is of great importance in the field of medicine. With the help of a flow chart, show how this technology has been used in preparing genetically engineered human insulins.
State the best-known contribution of P.K. Sethi
Which of the following is a neuropeptide hormone?
With regard to insulin choose the correct options.
- C-peptide is not present in mature insulin.
- The insulin produced by rDNA technology has C-peptide.
- The pro-insulin has C-peptide.
- A-peptide and B-peptide of insulin are interconnected by disulphide bridges.
Choose the correct answer from the options given below.
The Adenosine deaminase deficiency results in ______.
Name the five key tools for accomplishing the tasks of recombinant DNA technology. Also mention the functions of each tool.
How does a gene therapy involving direct modification of the cells, in order to achieve a therapeutic goal is used in the treatment of ADA deficiency? Explain.
- Assertion: PCR is a powerful technique to identify genetic disorders.
- Reason: PCR can detect mutations in low amounts of DNA.
Severe Combined Immunodeficiency Disease (SCID) caused by adenosine deaminase (ADA) deficiency arises due to which pathological mechanism?
